文献速递肾小球疾病

肾小球疾病研究与试验联盟:促进合作与创新的基层倡议

The Glomerular Disease Study and Trial Consortium: A Grassroots Initiative to Foster Collaboration and Innovation.
PubMed 文献 · Kidney Int Rep · 2018-09-21

本文报告了一个旨在为肾内科医生、病理学家、基础与临床科学家、患者及产业伙伴提供合作机会的「基层」倡议。该倡议包括开放获取的网络多学科临床视频病例会议、多站点纵向临床数据与生物样本库研究,以及患者临床试验联系登记。这些活动有望促进更紧密合作并克服肾小球疾病领域的进展障碍。

要点

  • 倡议提供开放获取的网络多学科视频病例会议,促进临床与病理知识交流。
  • 多站点研究建立纵向临床数据与生物样本库,收集病史、血尿样本及DNA。
  • 患者可独立注册补充联系登记,以便符合条件时参与临床试验。

核心结论

  • 该基层倡议通过多学科协作和共享资源,可能有助于克服肾小球疾病领域的进展障碍。

研究设计与样本

  • 本文描述了一个基层倡议的创建,包括开放获取的网络多学科临床视频病例会议和多站点前瞻性纵向临床数据与生物样本库研究。

主要发现

  • 倡议活动包括视频病例会议、多站点研究(收集定期更新的基于本体的病史、间隔收集的血尿样本、DNA及患者联系登记)以及外部科学家可访问数据库进行研究。

临床怎么用

  • 肾内科医生、病理学家、科学家和患者可参与视频病例会议和生物样本库研究,以促进合作和临床研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glomerular kidney disorders account for a significant proportion of chronic kidney disease and end-stage renal disease worldwide. Nevertheless, major obstacles make breakthrough progress in diagnosis and cure an ongoing challenge. Here we report the creation of a "grassroots" initiative that aims to provide new opportunities for nephrologists, pathologists, basic and clinical scientists, patients, and industry partners to collaborate in the field of glomerular kidney disease. Members of the medical community, including trainees, nephrologists, and nephropathologists, can participate in the open-access, Web-based, multidisciplinary clinical video case conferences, which provide "peer-to-peer" exchange of clinical and pathological expertise combined with a formal didactic curriculum. Participants can also join other aspects of the broader initiative. These include the participation in a multisite research study to facilitate enrollment of patients into a longitudinal clinical data and biorepository for glomerular kidney disorders. Items included in this prospective registry include the following: an ontology-based patient medical history, which is regularly updated; interval collection and storage of blood and urine samples; DNA collection; and a contact registry for patients who wish to participate in clinical trials. Participating sites and external scientists can leverage access to the database to pursue genetic, biomarker, epidemiological, and observational clinical effectiveness studies. Patients can independently sign up for a supplementary contact registry to participate in clinical trials if eligible. The broad spectrum of activities within this initiative will foster closer collaboration among trainees, practicing nephrologists, pathologists, and researchers, and may help to overcome some of the barriers to progress in the field of glomerular kidney disease.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Poyan Mehr A, Sadeghi-Najafabadi M, Chau K, et al. The Glomerular Disease Study and Trial Consortium: A Grassroots Initiative to Foster Collaboration and Innovation. Kidney Int Rep. 2018. PMID: 30596165. doi:10.1016/j.ekir.2018.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。